Clinical course and management of acute hepatitis A infection in adults

Ann Hepatol. 2012 Sep-Oct;11(5):652-7.

Abstract

Background: Hepatitis A is the most common type of viral hepatitis in Mexico. The change of hepatitis A epidemiology in Mexico from high to intermediate endemicity leads to increasing susceptible adults for severe illness.

Objective: To describe the clinical characteristics and hospital outcome of adult patients with acute hepatitis A infection, and determine risk factor for mortality.

Material and methods: This is a retrospective observational, multicentre study in Mexico City and in Guatemala City. All inhospital patients were followed until discharge or death. Risk factors for death/acute liver failure were identified.

Results: Forty seven patients were analyzed, sixty percent were male, the prodrome phase was from 3 to 30 days. The three most common symptoms were fever, malaise and jaundice, with 87%, 74% and 62% respectively. The incidence of patients who were treated with antibiotics before hospital admission was up to 34%. Unnecessary imaging studies and out of guidelines drugs were used. Presence of encephalopathy, leukocytes > 19,000/mL, blood urea nitrogen > 36 mg/dL, creatinine > 2 mg/dL, albumin < 2.5 mg/dL and total bilirubin > 9.6 mg/dL, are predictors of mortality. Serum creatinine > 2 mg/dL has the best sensibility and specificity for predicting fulminant hepatitis/death.

Conclusion: Acute hepatitis A infection in adults is associated some unnecessary diagnostic and therapeutic approach. Could be associated with fulminant hepatitis, and a creatinine value > 2 mg/dL is the best predictor for fulminant hepatitis and death.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Biomarkers / blood
  • Disease Progression
  • Female
  • Guatemala / epidemiology
  • Hepatitis A / blood
  • Hepatitis A / diagnosis
  • Hepatitis A / drug therapy*
  • Hepatitis A / mortality
  • Humans
  • Liver Failure, Acute / drug therapy
  • Liver Failure, Acute / mortality
  • Liver Failure, Acute / virology
  • Male
  • Mexico / epidemiology
  • Predictive Value of Tests
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Unnecessary Procedures
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents
  • Biomarkers